Suicide | Effectiveness of a Family-Based Intervention for Adolescent Suicide Attempters (The SAFETY Study)
Suicide research study
What is the primary objective of this study?
This study will evaluate the effectiveness of an individually tailored suicide prevention treatment program called SAFETY in reducing suicide and suicide attempts in adolescents.
Who is eligible to participate?
Inclusion Criteria: - Suicide attempt in the 3 months before study entry Exclusion Criteria: - Psychosis - Substance dependency - Immediate risk of out-of-home placement - Symptoms/conditions that would interfere with assessment and/or intervention protocols
Which medical condition, disease, disorder, syndrome, illness, or injury is researched?
Interventions can include giving participants drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available or noninvasive approaches such as surveys, education, and interviews.
Behavioral:SAFETYParticipants will receive a family-based cognitive behavioral therapy intervention called SAFETY for 12 weeks. The SAFETY intervention is an individually tailored intervention strategy that integrates (1) family- and community-based interventions aimed at mobilizing family and community networks that support youth safety, adaptive behavior, and reasons for living; (2) cognitive behavioral treatment modules that focus on decreasing suicidality and preventing repeat suicide attempts; and (3) an individualized care linkage strategy that links youth to needed services and resources.
Behavioral:Enhanced usual careEnhanced usual care will include treatment as usual enhanced by study support.
Research studies and clinical trials typically have two or more research arms. An arm is a group of people who receive the same treatment in the study.
SAFETY IPhase I participants who will receive SAFETY
SAFETY IIPhase II participants who will receive SAFETY
ControlPhase II participants who will receive enhanced usual care
Start Date: March 2006
Completed Date: September 2016
Phase: Phase 1/Phase 2
Primary Outcome: Hospitalization
Study sponsors, principal investigator, and references
Principal Investigator: Joan R. Asarnow, PhD
Lead Sponsor: University of California, Los Angeles
Collaborator: National Institute of Mental Health (NIMH)